REGISTRATION IS NOW CLOSED DUE TO MAXIMUM NUMBER OF PARTICIPANTS REACHED
The 9th Swiss-Scandinavian Bio-Business Seminar is organized by the Nordic countries in cooperation with Swiss partners. During this high-level partnering and investor conference, Swiss and Nordic biotech and pharmaceutical companies as well as investors meet in one-to-one meetings and present themselves in plenum.
The goal of the conference and by means of the Swiss-Nordic focus is to establish new contacts and networks.
MS Ventures – Seventure Partner – Bay City Capital – Roche Venture Fund – Novartis Venture Fund – Sunstone Capital –Creathor Venture – Novo Seeds – Aravis – Endeavour Vision – Redalpine – Agire Invest – Index Ventures – Industrifonden – HBM Partners – Sarsia Seeds – NeoMed Management
Roche – Novartis – Pfizer – Takeda – MSD – Roche Diagnostics – Tillotts Pharma – Vifor Pharma – Alexion Pharma
FOR MORE INFO go to "About SSBBS".
![]() |
![]() |
Organisers |
---|
![]() |
Schedule | |
---|---|
Registration | 6 Sep – 26 Jan |
Meeting Selection | 15 Jan – 3 Feb |
Event | 5 Feb |
Details | |
---|---|
Language | English |
Venue | Zurich |
Bilateral Meetings | |
---|---|
Participants | 153 |
Meetings | 363 |
Participants | ||
---|---|---|
Belgium | 1 | |
Denmark | 10 | |
Finland | 13 | |
France | 6 | |
Israel | 1 | |
Italy | 1 | |
Norway | 9 | |
Spain | 1 | |
Sweden | 55 | |
Switzerland | 62 | |
United Kingdom | 1 | |
United States | 1 | |
Total | 161 |
Profile Views | |
---|---|
Before Event | 12429 |
After Event | 29689 |
Total | 42118 |